Dechra Sponsors Navicular Syndrome Awareness Week on The Horse
Look for educational information about navicular syndrome, or podotrochlosis, all week long, Jan. 16-22, 2022.
Share
ADVERTISEMENT
Using hoof testers to check for soreness is a standard part of a hoof-lameness exam. | Kevin Thompson/The Horse Staff
No owner wants to hear the work “navicular” during their horse’s lameness exam. It can mean the horse has podotrochlosis, a condition previously known as navicular syndrome or navicular disease, which can be careering- or life-ending. Fortunately, veterinarians now have more treatment options for helping keep horses comfortable and even serviceably sound.
To help educate horse owners about podotrochlosis, The Horse: Your Guide to Equine Health Care and Dechra have teamed up for Navicular Syndrome Awareness Week, Jan. 16-22, 2022. Dechra is the maker Osphos, an FDA-approved drug for the treatment of navicular syndrome in adult horses.
Look for more information about podotrochlosis all week on TheHorse.com, our Facebook page and Twitter feed, and in our e-newsletters.
Share
Written by:
Michelle Anderson
Michelle Anderson is the former digital managing editor at The Horse. A lifelong horse owner, Anderson competes in dressage and enjoys trail riding. She’s a Washington State University graduate and holds a bachelor’s degree in communications with a minor in business administration and extensive coursework in animal sciences. She has worked in equine publishing since 1998. She currently lives with her husband on a small horse property in Central Oregon.
Related Articles
Stay on top of the most recent Horse Health news with
